Compare ENTA & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTA | CVGW |
|---|---|---|
| Founded | 1995 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.3M | 463.3M |
| IPO Year | 2013 | N/A |
| Metric | ENTA | CVGW |
|---|---|---|
| Price | $12.85 | $26.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $20.40 | ★ $33.50 |
| AVG Volume (30 Days) | 283.1K | ★ 594.7K |
| Earning Date | 02-09-2026 | 01-14-2026 |
| Dividend Yield | N/A | ★ 3.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.11 |
| Revenue | $65,324,000.00 | ★ $648,434,000.00 |
| Revenue This Year | $0.99 | $13.89 |
| Revenue Next Year | $0.19 | $11.67 |
| P/E Ratio | ★ N/A | $23.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.09 | $18.40 |
| 52 Week High | $17.15 | $28.72 |
| Indicator | ENTA | CVGW |
|---|---|---|
| Relative Strength Index (RSI) | 41.35 | 80.84 |
| Support Level | $12.09 | $21.85 |
| Resistance Level | $13.98 | $22.46 |
| Average True Range (ATR) | 0.73 | 0.79 |
| MACD | -0.22 | 0.47 |
| Stochastic Oscillator | 19.01 | 76.43 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.